Irinotecan in Treating Aging Patients With Solid Tumors
Study Information
Alliance Study ID: CALGB-60001
NCT Study ID (ClinicalTrials.gov): NCT00026195
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Solid Tumors
Alliance Study Chair: Stuart M. Lichtman, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Aging may affect the way these drugs work.
PURPOSE: Phase I trial to determine the relationship between aging and the effectiveness of irinotecan in treating patients who have solid tumors.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information